Physician profile
Sam Gershenbaum
NPI 1013013127
$9,444.84
in general payments reported to CMS, 2019-2025
13 companies · $2,163 in 2025
The $2,163 reported for 2025 was more than what 86% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,229 · 2020: $514 · 2021: $130 · 2022: $698 · 2023: $169 · 2024: $3,542 · 2025: $2,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,006 · Travel and Lodging: $2,005 · Long Term Medical Supply Or Device Loan: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,006.38 |
| Travel and Lodging | $2,005.32 |
| Long Term Medical Supply Or Device Loan | $862.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,008.48 | 2023-2025 | |
| Allergan, INC. | $2,622.87 | 2019-2022 | |
| Integra Lifesciences Corporation | $931.55 | 2021-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $741.73 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tepha INC | $201.18 | 2019 | |
| Becton, Dickinson and Company | $181.07 | 2025 | Galaflex |
| Motiva USA, LLC | $159.84 | 2025 | |
| Stryker Corporation | $150.35 | 2024 | Spy-Phi System |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Revance Therapeutics, INC. | $89.60 | 2025 | Daxi |
| Kerecis Limited | $84.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solta Medical, A Division of Bausch Health US, LLC | $20.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Gershenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.